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Abstract 
The metabolism of carbohydrate 
polymers drives microbial diversity in 
the human gut microbiome. The 
selection pressures in this environment 
have spurred the evolution of a 
complex reservoir of microbial genes 
encoding carbohydrate-active 
enzymes (CAZymes). Previously, we 
have shown that the human gut 
bacterium Bacteroides 
thetaiotaomicron (Bt) can 
depolymerize the most structurally 
complex glycan, the plant pectin 
rhamnogalacturonan II (RGII), 
commonly found in the human diet. 
Previous investigation of the RGII-
degrading apparatus in Bt identified 
BT0997 as a new CAZyme family, 
classified as glycoside hydrolase 138 
(GH138). The mechanism of substrate 
recognition by GH138, however, 
remains unclear. Here, using synthetic 
substrates and biochemical assays, 
we show that BT0997 targets the D-
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galacturonic acid-α-1,2-L-rhamnose 
linkage in chain A of RGII and that it 
absolutely requires the presence of a 
second D-galacturonic acid side chain 
(linked β-1,3 to L-rhamnose) for 
activity. NMR analysis revealed that 
BT0997 operates through a double-
displacement, retaining mechanism. 
We also report the crystal structure of 
a BT0997 homolog, BPA0997 from	
Bacteroides paurosaccharolyticus, in 
complex with ligands at 1.6	 Å 
resolution. The structure disclosed that 
the enzyme comprises four domains, 
including a catalytic TIM (α/β)8 barrel. 
Characterization of several BT0997 
variants identified Glu-294 and Glu-
361 as the catalytic acid/base and 
nucleophile, respectively, and we 
observed a chloride ion close to the 
active site. The three-dimensional 
structure and bioinformatic analysis 
revealed that two arginines, Arg-332 
and Arg-521, are key specificity 
determinants of BT0997 in targeting D-
galacturonic acid residues.	 In 
summary, our study reports the first 
structural and mechanistic analyses of 
GH138 enzymes. 
 
Introduction 
The human gut microbiota (HGM) is a 
vast microbial community, of >109 
bacterial cells, inhabiting the distal 
human colon (1). The HGM is 
essential for maintaining human health 
by preventing colonisation of 
pathogens and providing secondary 
metabolites, which provide up to 10 % 
of the hosts calorific intake (2). When 
the HGM falls into a state of dysbiosis, 
potentially as a result of the hosts diet 
being deficient in fibre, it has been 
linked to a number of disease states 
such as colitis, colorectal cancer and 
even Alzheimer’s disease (3; 4; 5). 
Thus, a healthy HGM can be 
maintained by providing the 
community with a diet that is high in 
fibre (6). This fibre is in the form of 
plant glycans ingested by the host, 
which are then degraded by members 
of the HGM and utilised as a primary 
source of carbon.  Competition within 
the HGM is intense and bacteria of this 
community, such as those of the 
Bacteroidetes phyla, have evolved 
elaborate and complex mechanisms in 
the form of polysaccharide utilization 
loci (PUL) to acquire and degrade 
glycans. PULs are a set of co-localised 
and co-regulated genes that are 
dedicated to degrade a target glycan 
(7).  Understanding how the HGM 
degrades dietary fibre is therefore 
critical to devising pre and pro-biotic 
strategies to improve human health. 
This reservoir of carbohydrate active 
enzymes is also an invaluable source 
for the discovery of enzymatic 
activities 
 The pectic polysaccharide 
rhamnogalacturonan II (RGII) is highly 
conserved in terrestrial plants being 
found in the primary cell walls of fruits 
and vegetables (8). It is also highly 
enriched in luxury foods such as red 
wine and dark chocolate; as such is a 
common component of the human diet 
(9) . RGII is the most complex glycan 
known in nature comprising three 
unique sugars and 23 unique 
glycosidic linkages. It was unknown if 
a single organism could degrade the 
polymer or if a consortium of bacteria 
would be required. Recently, our group 
showed that Bacteroides 
thetaiotaomicron (Bt), a member of the 
Bacteroidetes phyla and a model 
organism for studying glycan 
metabolism by the HGM, is able to 
cleave all but one of the 23 distinct 
glycosidic linkages present in RGII by 
deploying three discrete PULs (10).  
The primary catalytic apparatus 
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encoded by PULs is in the form 
glycoside hydrolases (GH). GHs are 
catalogued on the CAZy database by 
sequence homology into unique 
families (http://www.cazy.org) (11). 
Members within a family have the 
same tertiary fold, catalytic apparatus 
and mechanism. As the complete 
degradative pathway utilised by Bt was 
dissected, seven new GH families 
were discovered and added to the 
CAZy database. One of these families, 
founded by the protein BT0997, was 
annotated as GH138 and was shown 
to be an α–D-galacturonidase targeting 
the α-1,2-D-galacturonic acid linked to 
rhamnose within RGII (10). In this 
paper, we describe the kinetic 
properties of BT0997 and its 
homologue WP_024993800 from 
Bacteroides paurosaccharolyticus 
(BPA0997). We also dissected the 
mechanism by which GH138 operates. 
Finally, the structural solution of 
BPA0997, in complex with ligands, 
allows the assignment of both the 
catalytic residues in the family and the 
amino acids that drive specificity. 
 
Results 
Biochemical properties of BT0997  
 In a previous study, we showed 
that BT0997 is a new family of α-1,2-D-
galacturonidase specifically targeting 
the D-galacturonic acid (GalA)-α-1,2-L-
rhamnose (Rha) contained within 
chain A of RGII  (Fig. 1A). It was also 
demonstrated that BT0997 was 
inactive on intact RGII and was only 
active after chain A (10) was released 
from the backbone by an endo acting 
Polysaccharide Lyase 1 (PL1) and 
concomitant removal of both α-L-
galactose, by BT1010, and β-D-
glucuronic acid, by BT0996, from the 
top of chain A. After this initial 
degradation, BT0997 is then able to 
act and its action is required for further 
degradation of chain A. The 
mechanism of substrate recognition 
displayed by the enzyme, however, 
remained unclear. In the present 
study, we used synthetic substrates 
(Fig. 1BC) and showed that BT0997 
recognise the second β-linked GalA as 
an absolute specificity determinant. 
The enzyme was inactive on SN909 
which only contains one of the two 
GalA residues (D-GalA-α-1,2-L-Rha-α-
1,4-L-Fucose) whilst it displayed full 
activity against SN908, the doubly 
GalA decorated rhamnose substrate 
(D-GalA-α-1,2-L-Rha-β-1,3-D-GalA). A 
comparable activity was observed on 
G2RAX, a hexasaccharide produced 
by the growth of the deletion mutant 
Δbt0997 on RG-II.  The absence of 
BT0997 means that the α-1,2-D-GalA 
can no longer be cleaved, preventing 
the full digestion of chain A leading to 
the accumulation of the 
hexasaccharide G2RAX in the growth 
media. These data suggest that 
BT0997 has three subsites, a -1 
subsite where the GalA linked α-1,2 to 
Rha binds; a +1 subsite where Rha is 
situated, and finally a +2NR subsite 
where the second GalA β-1,3 linked to 
Rha binds (Table 1) (subsite 
nomenclature of GHs is such that bond 
cleavage occurs between the -1 and 
+1 subsites with the catalytic 
apparatus being housed at the -1 
subsite. Subsites then increase in 
number, +2, +3 etc. toward the 
reducing end of the glycan and 
decrease in number, -2, -3 etc. toward 
the non-reducing end of the glycan). 
As BT0997 was the founding member 
of a new GH family (GH138) we 
endeavoured to reveal its catalytic 
mechanism. GHs typically operate 
through two catalytic mechanisms; an 
inverting mechanism, which is a single 
displacement reaction causing 
inversion of the anomeric configuration 
of the product compared to the 
substrate, or a retaining mechanism, 
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that is a double displacement reaction 
proceeding via a covalent 
intermediate, causing retention of the 
anomeric configuration in the products, 
with respect to the substrate (Fig. 2). 
The 1H-NMR spectra of the synthetic 
substrate SN910 was recorded prior to 
and at intervals after the addition of 
BT0997. This allowed the monitoring 
of the stereochemical course of the 
reaction, and is shown in Fig.  2.  After 
one minute of incubation a doublet at 
about 5.22 ppm, assigned to  H-1α of  
GalA (12) appeared and rapidly  
increased  in  intensity.  Later in the 
incubation a small doublet at 4.5 ppm, 
due to H-1β of GalA, became 
noticeable and is from the mutarotation 
of the initially formed α-anomer. 
Therefore, the data clearly indicate 
that BT0997 catalyzes the hydrolysis 
of D-GalA-α1,2-L-Rha linkages at the 
non-reducing end of the 
oligosaccharide with retention of the 
anomeric configuration.  
Crystal Structure of BPA0997 
 Attempts to crystallise BT0997 
proved unsuccessful, probably due to 
the heterogeneous oligomeric states 
and soluble aggregates formed by the 
protein, as evidenced by size 
exclusion chromatography (Fig. S1). 
WP_024993800 from Bacteroides 
paurosaccharolyticus (BPA0997), a 
homologue that shares 70% identity 
with BT0997, displayed the same 
specificity as BT0997 and also had 
maximal activity on Rha decorated 
with both α-1,2 and β-1,3 linked GalA. 
BPA0997 produced two peaks when 
purified by size exclusion 
chromatography, corresponding to a 
monomeric and dimeric state (Fig. 
S1). Protein corresponding to the 
monomeric state was carried forward 
into crystallographic trials. As BT0997 
and BPA0997 are the founding 
members of the GH138 family, no 
corresponding structure was available 
in the Protein Data Bank (PDB). The 
structure of BPA0997 was solved by, 
selenomethionine (SeMet), single 
wavelength anomalous X-ray 
scattering to a resolution of 2.00 Å 
(Table 2) (PDB code 6NZF). The 
SeMet protein crystallised in the 
primitive space group P212121 and had 
two molecules in the asymmetric unit. 
BPA0997 is composed of four domains 
(Fig. 3). The N-terminal domain (ND1; 
residues 23 - 132) is made up of a 
five-stranded mixed beta sheet with 
two parallel alpha helices beneath the 
sheet.  The fifth beta strand of the ND1 
continues into the catalytic TIM barrel 
domain (D2; residues 133 - 468) 
which, has a central barrel of eight 
beta strands, 3-10, and is spiralled 
around by alpha helices 1-8. The third 
domain (D3; residues 469 – 724) 
comprises 7 alpha helices, 11-17, 
which bundle together and run 
antiparallel to each other. Finally, the 
C-terminal domain (CD4; residues 725 
– 893) presents a beta-sandwich fold.  
ND1 makes few interactions with the 
TIM barrel domain and displays higher 
average B factors compared to the rest 
of the domains. Hydrophobic and polar 
contacts are made, however, between 
F86, Y107 and E111 from ND1 and 
W485 and R183, respectively, from the 
TIM barrel domain. The interface area 
between ND1 and D2 is 827.5 Å2. The 
D3 alpha helical bundle domain 
interacts with the TIM barrel through 
apolar interactions; F485, F482 and 
W478 from helix 11 and Y500 and 
P508 from helix 12, with W401 P404 
and F406 from alpha helix 9 and W454 
and Y463 from alpha helix 10 of the 
TIM barrel. These extensive 
interactions are reflected in the total 
surface interface of 2510.2 Å2. The 
CD4 domain makes almost no 
interactions with the TIM barrel but sits 
on its top, burying a surface area of 
504.8 Å2. The CD4 domain appears to 
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‘lock’ into the active site with an 
extended loop (R814-S820) that would 
prevent substrate binding. A 
glutamate, E816, in the extended loop 
makes polar interactions with R521 
and H542 forming a potentially ‘ionic 
lock’ that secures the CD4 domain 
over the active site (Fig. 3BC). It is 
also possible that the location of the 
CD4 domain over the anterior surface 
of the TIM barrel is a consequence of 
the crystal packing. Indeed, the C-
terminal linking loop makes close 
contacts with its symmetry related 
copy resulting in the CD4 domain 
occluding the active site. Additionally, 
the CD4 domain makes contact with 
the helical domain of a symmetry 
related mate. Thus, considering that 
BPA0997 displays activity in solution 
and that only few interactions occur 
between the catalytic domain and the 
CD4 domain, it is possible that out of 
the crystal context, the CD4 domain is 
mobile and could be involved in 
substrate recognition instead of 
preventing substrate binding. 
Active site interactions of BPA0997 in 
complex with ligands. 
In spite of the active site being blocked 
by the CD4 domain both a serine 
(Ser), in the SeMet structure (which 
comes from the crystallization 
condition and is not biologically 
relevant so will not be discussed 
further), and a GalA, in the full-length 
E361S inactive mutant (co-
crystallization with GalA) can be 
observed in the -1 active site, Fig. 3. 
These data suggest that the CD4 
domain could close over a covalently 
bound GalA in the -1 subsite. As 
discussed earlier, the recognition of 
the β-1,3 Rha linked GalA at the +2NR 
subsite is crucial for enzyme activity. 
To identify the key residues 
responsible for this feature, a 
BPA0997-G2RAX complex was 
necessary. However, the loop from the 
CD4 domain is likely to prevent the 
binding of G2RAX by blocking the 
active site in the crystal context. Thus, 
a C-terminally truncated version, 
eliminating residues 719 – 893 of 
BPA0997 (BPA0997ΔCT) was 
designed. This mutant enzyme 
displayed the same catalytic efficiency 
on G2RAX than the full-length enzyme 
(Table 1). Crystals of the inactive 
mutant BPA0997ΔCTE361S showed that 
the protein crystallised in the space 
group P22121 with one molecule in the 
asymmetric unit. Some crystals were 
thus soaked with a mixture of G2RAX 
and GRAX containing no free GalA 
(see methods for substrate generation 
and purification) and a 1.6 Å resolution 
structure was obtained. Although a 
complex was observed, only two GalA 
residues could be reliably built. The -1 
GalA adopts both α and β anomers, 
whilst the +2NR GalA, which is 
partially disordered, could only be 
modelled as the β anomer.  The O1 
positions of the -1 α-GalA and the 
+2NR β-GalA are well positioned to be 
connected to the O2 and O3 of Rha, 
respectively (Fig S2). There is some 
density suggesting a glycosidic linkage 
from the +2NR GalA to Rha but not for 
the Rha molecule itself. Also, there is 
no evidence of a connection between 
the -1 GalA and the Rha. This 
suggests that BPA0997ΔCTE361S had 
retained some residual catalytic 
activity against G2RAX and is likely 
bound to GalA and GRAX. The GRAX 
cannot be reliably built into the 
observed electron density, however, 
due to disorder.  
Superimposition of the full-length 
native protein with BPA0997ΔCTE361S , 
reveals  that E361 (sitting atop β-
strand 4) sits 3.5 Å from the anomeric 
carbon of the -1 GalA sugar and is 
therefore the perfect candidate to be 
the catalytic nucleophile. E294 (sitting 
atop β-strand 6), on the other hand, is 
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located at ~3 Å away from O1 of the -1 
GalA and therefore should be fulfilling 
the role of the catalytic acid/base. 
E361 and E294 are ~5.7 Å apart which 
is well in line with the expected ~5.5 Å 
for catalytic residues in retaining 
enzymes. Their catalytic role is 
confirmed by the observation that the 
BPA0997 mutants E294S, E294Q, 
E361S and E361Q are inactive when 
assayed biochemically (Table 2 and 
Fig. S3).  
Interactions involving non-catalytic 
residues 
The GalA at -1 makes several other 
interactions, mainly via its carboxylic 
acid group, forming a bidentate ionic 
interaction with R332. K357 and Y241 
also interact with the carboxylic acid 
with K357 making a potential hydrogen 
bond to the endocyclic oxygen. 
Mutation of R332 or K357 to an 
alanine completely abolishes 
enzymatic activity, emphasising the 
importance of these positively charged 
residues. The -1 GalA interacts with 
Oδ1 and NH2 of N520 via O2 and O3 
respectively. The axial O4 of the -1 
GalA, which is the unique chiral 
position of GalA, interacts with H391 
via Nε2. Mutation of this residue to an 
alanine completely knocks out catalytic 
capability of the enzyme. The effect of 
Y241 is less detrimental, but still 
significant, suffering a ~72 fold loss in 
activity. There is a partially disordered 
GalA occupying what will be termed 
the +2NR subsite. Occupation of this 
subsite is critical for enzymatic activity 
and the interaction with the protein 
seems to be dominated by the 
carboxylic acid group forming a 
bidentate interaction with R521. 
Additional interactions are potentially 
made by T517 and E518 with O3 and 
O4, respectively, however, the electron 
density for this part of the sugar is 
weak and may be reflective of the 
relative contribution of these 
interactions compared to R521. 
Circular dichroism was performed on 
the inactive mutants with the data 
demonstrating they were properly 
folded (Fig S4). Thus, inactivity was 
due to loss of the amino acid sidechain 
in these mutants (Table 2).    
Chloride binding Site 
Also, in the vicinity of the active site is 
a chloride anion which is coordinated 
by NH1 and NH2 of R332, Nδ2 of 
N389 and a water molecule (Fig 4). 
This is in agreement with the 
coordination sphere of the majority of 
the chloride anions observed in the 
protein crystal structures deposited in 
the PDB (13). Chloride anions have 
previously been observed to play an 
important role in the action of α-
amylases. The anion binds to a 
common site close in the vicinity of the 
active site where it assists in the 
reaction mechanism (14). As R332 
and N389 are two highly conserved 
residues (Fig 4, 5), we wanted to know 
whether the chloride anion present in 
BPA0997 is essential for catalytic 
activity. We attempted to remove NaCl 
from BPA0997 by gel filtration using 25 
mM Hepes, pH 7.0, as the buffer, a 
method described previously (15). The 
reaction on G2RAX was subsequently 
performed post gel filtration in 25 mM 
Hepes, pH 7.0, with no chloride added. 
The enzyme was still active (data not 
shown) suggesting that the anion is 
not required for catalytic activity or that 
the anion is too tightly bound to be 
removed by the method described 
above.   
Bioinformatic analysis 
Sequence alignments of the top 
500 results returned from Blastp, using 
BT0997 as the input sequence, reveal 
that all but 21 sequences show 
conservation of the catalytic residues 
E294 and E361, the acid/base and 
nucleophile, respectively. In addition 
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the two arginine residues R332 and 
R521, which coordinate the carboxylic 
acid groups of the -1 and +2NR GalA 
residues and are required for activity, 
are also invariant in these 479 
sequences (Fig. 5). These two 
arginine residues are likely the key 
specificity determinants for GH138 
enzymes in targeting GalA residues in 
double substitutions. This 
demonstrates that BT0997 is very well 
conserved in organisms where it is 
found and therefore its function. The 
observation that three sequences 
retain both catalytic residues and R332 
but not R521 may suggest that these 
protein sequences encode catalytically 
active enzymes but target residues 
where only one acidic sugar 
substitutes the +1 residue. The one 
sequence, which retains both catalytic 
amino acids, but neither of the basic 
arginines, may encode an enzyme 
targeting neutral sugars at the -1 
subsite.  
 
Discussion 
 BT0997 and BPA0997 are well 
conserved in the PULs of RGII 
degrading organisms suggesting it is 
an important part of the degradative 
apparatus. Indeed, the genetic 
knockout of bt0997 in Bt causes 
degradation of chain to cease at the 
point of the target linkage causing the 
undigested hexasaccharide, G2RAX 
from chain A, to be left over in the 
growth media (10). There are 
examples where multiple decorations 
of sugar residues causes a specific 
stereochemical blockage to cleavage 
of the glycosidic bond, of the sugar to 
which they are appended too. This 
requires the evolution of enzymes that 
are specifically targeted to these 
residues. BT0997 and its homologues 
are part of a small number of glycoside 
hydrolases that have evolved to 
address this problem. The ability to 
target these residues usually places 
the requirement that both of the 
decorating sugars are required for 
activity and creates a more open 
active site cavity. This has resonance 
with the AXHd3, an 
arabinofuranosidase from Humicola 
insolens, that specifically targets the α-
1,3-L-arabinofuranose residues on 
doubly decorated xylose (16). The 
enzyme, analogous to BT0997, 
requires both the α-1,3-L-
arabinofuranose and α-1,2 
substitutions to be active but only 
cleaves the α-1,3 linkage.  
A Dali search using the 
BPA0997ΔCT showed no significant 
structural homologs in the PDB 
database. The top three results were a 
GH67 (1K9E), GH115 (4C91) and a 
GH20 (4C7D), with the best result 
(GH67) having only 11 % identity, an 
root-mean-square deviation (RMSD) of 
3.6 Å over 499 residues and a Z score 
of only 18.7. These three enzymes 
also utilize different mechanisms to the 
GH138 with GH67 and GH115 utilising 
an inverting mechanism whilst GH20 
operate through a substrate assisted 
mechanism. These data point to very 
little ancestry between the top hits 
from the Dali search and GH138 
enzymes. GH67, however, also 
contains ND1 and a domain similar to 
D3 but lacks the CD4 domain. A Dali 
search was also run with ND1, D3 and 
CD4 individually. ND1 matches the N-
terminal domains of several other 
GH67 members, with 1LN8 being the 
best match with a RMSD of 1.8 Å, an 
identity of 20 % but a Z-score of only 
13.6. The D3 domain best matched 
2R03 which is involved in apoptosis 
and adopts a similar, extended, alpha 
helical fold. The Dali results, however, 
were poor having an RMSD of 2.7 Å, 
an identity of 6 % and a Z-score of 9.4. 
The CD4 domain returns some 
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evidence for similar folds in several 
other CAZyme families. Again the 
similarities were low with an RMSD of 
3.1 Å, an identity of 8 % and a Z-score 
of 3.6. Further inspection of the 
overlays of these three structures with 
BPA0997 reveals that there are no 
gross similarities between the active 
sites, however, some commonalities 
can be observed with GH67. GH67 are 
predominantly xylan α-1,2-D-
glucuronidases and R318  is 
invariantly conserved when a Blastp is 
performed using 1K9E. This residue 
corresponds to R332 in BPA0997. This 
demonstrates that GH67 and GH138 
coordinate the carboxylic acids, 
glucuronic acid and GalA, respectively, 
in the same manner. The catalytic 
nucleophile E361 also is spatially 
similar to the D364 in GH67, but D364 
likely acts as a catalytic acid.  
The structure of the BPA0997 revealed 
a TIM barrel fold, a common tertiary 
fold observed in many GH families and 
particularly in the Clan A class of 
enzymes. BPA0997 constitutes a new 
family and is not part of clan A as the 
catalytic residues are not found on β 
strands 4 and 7, but rather β strands 4 
and 6, of the central barrel and the 
catalytic acid is not part of the 
NEP/HEP motif found in clan A 
enzymes (17). Presumably, if its 
evolutionary origins are distinct, and as 
other members are discovered in the 
future, it may form part of a new clan. 
The same may be said of the other 
three domains. These are not new 
folds but the poor values from the Dali 
search may imply very distant 
evolutionary relationships or again 
evolving from unique progenitor 
sequences. The role of the CD4 
domain remains ambiguous as no 
effect on catalytic activity, and 
presumably stability, was observed 
with its removal. However, such ‘ionic 
locks’ securing loop conformers in 
CAZymes have been observed before, 
notably in the recently discovered 
PL27 and CjMan26C where removal of 
these features heavily impacted in 
enzyme function (18; 19). It is 
plausible that the effects of removing 
the CD4 domain could be masked by 
measuring only the kcat/KM against 
G2RAX (due to limited substrate full 
kinetic parameters could not be 
derived).  Although G2RAX and the 
CD4 domain cannot occupy the same 
space, the CD4 domain may close 
over the covalently bound -1 GalA and 
concomitantly drive departure of the 
leaving group helping to create a 
closed microenvironment for the 
second stage of catalysis. This would 
then require the CD4 domain to move 
out of the active site before the -1 
GalA could depart and allow a new 
catalytic cycle. Thus, removal of the 
CD4 domain would lose this 
‘microenvironment’ but could allow the 
-1 GalA to dissociate faster at the end 
of the catalytic cycle. This could raise 
both the KM and kcat by commensurate 
levels and thus no effect could be 
observed measuring only kcat/KM. This 
is a limitation when substrate is 
bespoke and limited.  
 
Conclusions 
This study describes the first structural 
and mechanistic analysis of GH138, 
characterising the proteins BT0997 
and BPA0997. Both enzymes target 
the L-Rha-α-1,2-D-GalA linkage 
contained within chain A of RGII. The 
enzymes target, and require, 
rhamnose that is double substituted 
with GalA using two invariant arginines 
to drive specificity; performing 
catalysis through a double 
displacement, retaining, mechanism.  
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Materials and methods 
 
Cloning, Expression, and Purification 
of BT0997 and of its Homologue 
BPA0997—All recombinant forms of 
proteins used in this study were 
expressed in the cytoplasm of 
Escherichia coli. The gene encoding 
BT0997 (locus identifier: BT_0997, 
NCBI Reference Sequence: 
NC_004663.1) was described 
previously (10). DNA encoding 
Bacteroides paurosaccharolyticus 
GH138 (BPA0997, NCBI Reference 
Sequence: WP_024993800.1) was 
initially generated by GeneArt gene 
synthesis (Thermo Fisher Scientific). 
BPA0997 construct was cloned such 
that the encoded protein contains a C-
terminal His6 tag. BPA0997 constructs 
were cloned in the pET_SUMO vector 
displaying a modified MCS (provided 
by Dr. Patrick Moynihan from 
University of Birmingham) such that 
the encoded proteins contain a N-
terminal SUMO tag that is 
subsequently removed by a specific 
protease following the instructions 
provided by the Champion™ pET 
SUMO Protein Expression System kit 
protocol. Site-directed mutagenesis 
was carried out using the PCR-based 
QuikChange method (Stratagene). To 
express the recombinant proteins, E. 
coli strain Tuner (DE3), harbouring 
appropriate recombinant plasmids, 
was cultured to mid-exponential phase 
in Luria broth at 37 °C supplemented 
with 10 µg.mL-1 kanamycin. Isopropyl 
β-D-galactopyranoside to a final 
concentration of 0.2 mM was then 
added to induce recombinant gene 
expression, and the culture incubated 
for a further 18 h at 16 °C. Cells were 
harvested by centrifugation at 4,424 × 
g for 10 min and resuspended in 20 
mM Tris·HCl buffer, pH 8.0, containing 
300 mM NaCl. Cells were lysed by 
sonication, and the cell-free extract 
was recovered by centrifugation at 
27,216 × g for 30 min. The 
recombinant proteins were purified to 
90% electrophoretic purity by 
immobilized metal ion affinity 
chromatography using TalonTM 
(Clontech), cobalt based matrix, and 
elution with 100 mM imidazole, as 
described previously (20) When 
preparing the selenomethionine 
derivatives of BPA0997 constructs for 
crystallography, the proteins were 
expressed in E. coli B834 (DE3), a 
methionine auxotroph, cultured in 
medium comprising 1 litre of 
SelenoMet MediumBaseTM, 50 ml of 
SelenoMetTM nutrient mix 
(MolecularDimensions), and 4 ml of a 
10 mg.ml-1 solution of L-
selenomethionine.  Recombinant gene 
expression and protein purification 
were as described above. For 
crystallographic studies, BPA0997 
constructs were further purified by gel-
filtration chromatography using 
Superdex HiLoad 16/600 200 pg (GE 
Healthcare). The elution buffer was 20 
mM Na-Hepes, pH 7.5, 150 mM NaCl. 
 
Oligosaccharides production and 
purification - RGII derived 
oligosaccharides: Bacteroides 
thetaiotaomicron strains containing 
specific gene deletions for bt0997 
(generates G2RAX) and bt0992 
(generates GRAX) were inoculated 
into minimal medium containing 1% 
RGII and grown in glass test tubes for 
48 h at 37 oC, in an anaerobic cabinet 
(Whitley A35 Workstation; Don 
Whitley, UK) to an OD600nm of 2.0. 
Cells were harvested by centrifugation 
initially at 2400 x g for 10 min and later 
at 17000 x g for another 10 min.  The 
resulting supernatant was filtered 
through a 0.2 µm syringe filter (VWR) 
and separated on two Bio-Gel P2 
(Biorad) size-exclusion columns (2.5 
cm x 100 cm), ran in series, and eluted 
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with 50 mM Acetic acid at 0.2 ml.min-1.  
Fractions (1 ml) were collected and 
analysed by TLC using orcinol/sulfuric 
acid to reveal the resolved sugars. 
Fractions containing oligosaccharides 
of interest were pooled and 
concentrated by freeze-drying using a 
CHRIST Gefriertrocknung ALPHA 1-2 
freeze-dryer (Helmholtz-Zentrum 
Berlin) at -50oC (10). The synthetic 
substrates SN908, SN909 and SN910 
were prepared using protocols outlined 
previously (21; 22). 
 
Enzyme assays-All enzyme assays 
unless otherwise stated were carried 
out in 20 mM sodium phosphate 
buffer, pH 7.0, containing 150 mM 
NaCl and performed in triplicate. 
Assays were carried out with 100 nM -
1 µM enzyme against 100-300 µM 
substrate at 37 °C. Aliquots were taken 
over a 16 h time course, and samples 
and products were assessed by TLC 
and high pressure anion exchange 
chromatography (HPAEC) with pulsed 
amperometric detection. Sugars were 
separated on a Carbopac PA1 guard 
and analytical column in an isocratic 
program of 100 mM sodium hydroxide 
and then with a 40 % linear gradient of 
sodium acetate over 60 min. Sugars 
were detected using the carbohydrate 
standard quad waveform for 
electrochemical detection at a gold 
working electrode with an Ag/AgCl pH 
reference electrode. 
Spectrophotometric, quantitative, 
assays for BT0997 and BPA0997 were 
monitored by the formation of NADH, 
at A340nm using an extinction coefficient 
of 6230 M−1 cm−1, with an 
appropriately linked enzyme assay 
system. The assays were adapted 
from purchased Megazyme 
International assay kit D-glucuronic 
acid/D-galacturonic acid assay kit (K-
URONIC). A single substrate 
concentration was used to calculate 
catalytic efficiency (kcat/KM) and was 
checked to be <<KM by halving and 
doubling the substrate concentration 
and observing an appropriate increase 
or decrease in rate. The equation V0 = 
(kcat/KM)[S][E] was used to calculate 
kcat/KM. 
Circular dichroism-Concentrated 
proteins were diluted to 500nM in 50 
mM sodium phosphate pH 7.0, and 
analysed with a JASCO J8-
10 spectropolarimeter in a 1 mm 
pathlength quartz cuvette. Samples 
were scanned from 190 nm to 260 nm 
at 20 nm.min-1 with a bandwidth of 2 
nm and a response time of 8 
seconds. 9 CD scans were performed 
per sample at 37 °C and the runs 
averaged. Raw spectra were analysed 
using the BestSel server (23).	
Crystallization, data collection, 
structure solution and refinement- 
Crystallization screening was 
undertaken with the robotic nanodrop 
dispensing systems (mosquito LCP; 
TTPLabTech) using commercial 
screens. Selenomethionine (SeMet) 
derivative crystals of BPA0997 were 
initially obtained in Morpheus H10 
(Molecular Dimensions). SeMet 
BPA0997 were manually optimized 
and single crystals were obtained as 
follows: 1 µl of enzyme at 12 mg.ml-1 
was mixed with 1 µl of a 1 ml reservoir 
solution containing 100 mM 
Tris(base)/bicine buffer pH 8.5, 30 mM 
of each amino acids (glutamate; 
alanine; glycine; lysine; serine), 8% v/v 
ethylene glycol and 16% w/v PEG 
8000 in hanging drops at 20 °C. Prior 
to flash-cooling in liquid nitrogen, 
single crystals were cryo-protected 
with 20% w/v PEG 400. As no 
appropriate molecular replacement 
model was available for BPA0997 in 
the Protein Data Bank, the structure 
was solved with experimental phasing 
by SeMet-SAD (single wavelength 
anomalous diffraction). A fluorescence 
energy scan was performed around 
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the selenium K atomic absorption edge 
of 12658 eV, confirming the presence 
of selenomethionine in the sample, 
and a SAD data set was collected at 
the optimal peak wavelength of 0.979 
Å. Diffraction data were collected at 
the Diamond Light Source, Didcot, 
United Kingdom, on beamlines I03, I04 
and I24 at a temperature of 100 K. 
Data were indexed and integrated with 
XDS (24) and scaled using Aimless 
(25). Space groups were confirmed 
using Pointless (25). Phases were 
determined experimentally using the 
anomalous scattering from the 
selenium atoms with the SHELXC/D/E 
(26) suite using HKL2MAP. The 
structure was built automatically in 
Buccaneer (27) and ARP_wARP (28) 
consecutively. Native crystals of the 
mutant BPA0997E361S were obtained in 
presence of 100 mM D-galacturonic 
acid in 30 mM sodium fluoride, 30 mM 
sodium bromide, 100 mM 
imidazole/MES pH 6.5, 25 % 2-methyl-
2,4-pentanediol. BPA0997ΔCTE361S 
crystals were obtained in 9 % butanol, 
100 mM Tris pH 8.4 and 16% PEG 
8000. The data were integrated and 
indexed with XDS (24) or Xia2 (29) 
and scaled with Aimless (25). The 
phase problem for both mutant was 
solved by molecular replacement using 
the SeMet model with Molrep (30) or 
Phaser (31). For all data, five percent 
of the observations were randomly 
selected for the Rfree set. The models 
underwent recursive cycles of model 
building in Coot (32) and refinement 
cycles in Refmac5 (33). The models 
were validated using Coot (32) and 
MolProbity. Structural figures were 
made using Pymol (The PyMOL 
Molecular graphics system, Version 
2.0 Schrodinger, LLC.) and all other 
programs used were from the CCP4 
suite (34). The data processing and 
refinement statistics are reported in 
Table 3. 
 
NMR Spectroscopy—All samples were 
diluted in 20 mM sodium phosphate 
buffer, pH 7.0, containing 150 mM 
NaCl, freeze-dried and resuspended 
three times in D2O before the 
experiment. Initial spectra were 
recorded with 800 µL of 12.5 mM S910 
in reaction buffer before initiating the 
reaction by the addition of 200 µL of 
BT0997 (final concentration, 30 µM). 
1H-NMR spectra were recorded in D2O 
on a Bruker Avance III HD 500 MHz 
NMR spectrometer operating at 500.15 
MHz at regular intervals. Each 
spectrum was acquired with 9 scans. 
Spectra of D-galacturonic acid (20 mM 
in reaction buffer) were also recorded. 
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List of abbreviations 
BPA = Bacteroides paurosaccharolyticus  
BT = Bacteroides thethaiotaomicron  
CAZymes = carbohydrate active enzymes  
CD4 = C-terminal domain of BPA0997 
D2 = TIM barrel domain of BPA0997 
D3 = third domain of BPA0997 
GalA = galacturonic acid pyranose form 
GH = glycoside hydrolases  
HGM = human gut microbiota  
ND1 = N-terminal domain of BPA0997 
PDB = Protein Data Bank  
PL = polysaccharide lyase 
PUL = polysaccharide utilization loci 
RGII = rhamnogalacturonan II  
Rha = rhamnose 
RMSD = root-mean-square deviation 
SAD = single wavelength anomalous diffraction 
SeMet = selenomethionine 
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G2RAX  
 
SN908 
 
SN909 
 
SN910 
 
BT0997 
(2.63 ± 0.1.8)  
x 104 
(4.12 ± 0.26)  
x 104 
ND 
(6.09 ± 0.18)  
x 103 
BPA0997 
(1.49 ± 0.07)  
x 105 
(3.63v± 0.13)  
x 105 
ND 
(1.04 ± 0.008)  
x 105 
BPA0997ΔCT 
(1.14 ± 0.031)  
x 103 
n/a n/a n/a 
Table 1. Kinetic parameters of BT0997 and BPA0997 against RGII 
oligosaccharides.  kcat/KM (min-1 M-1) were determined in 20 mM sodium phosphate pH 
7.0, 150 mM NaCl using 20 nM - 100 nM enzyme and 100 µM substrate. ΔCT refers to 
removal of the C-terminal domain of BPA0997. ND indicates that no significant activity 
was detected. n/a indicates activity was not tested.  
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G2RAX  
 
BPA0997 (Wt) (1.5 ± 0.1)  x 105  
E294S ND 
E294Q ND 
E361S ND 
E361Q ND 
R332A ND 
K357A ND 
H391A ND 
Y154A (1.15 ± 0.05) x 103 
W190A (8.80 ± 0.5) x 103 
Y241A (3.64 ± 0.3) x 102 
W432A (6.49 ± 0.2) x 103 
Y426A (2.17 ± 0.03) x 103 
Table 2. Kinetic parameters of BPA0997 wildtype and mutants against G2RAX.  
kcat/KM (min-1 M-1) were determined in 20 mM sodium phosphate pH 7.0, 150 mM NaCl 
using 20 nM - 100 nM enzyme and 100 µM substrate. ND indicates that activity could 
not be observed qualitatively (Fig. S2) and thus was not quantified. Errors are the 
standard errors of the mean from three independent experiments. 
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Data	collection	 BPA0997	(SeMet) BPA0997	E361S BPA0997ΔCT	E361S 
Date	  17/12/16 04/03/17 09/12/17 
Source I03 I04 I24 
Wavelength	(Å) 0.978 0.979 0.979 
Space	group P21 P21 P22121 
Cell	dimensions      
				a,	b,	c	(Å) 69.8	103.2	138.5 	69.5	107.4	139.2 55.30	68.38	220.16 
    α, β, γ 	(°)	 90.0	90.4	90.0 90.0	98.7	90.0 90.0	90.0	90.0 
No.	of	measured	
reflections 
1721396	(82026) 210454	(17375) 514191	(23838) 
No.	of	independent	
reflections 
134407	(6637) 55515	(4532) 100505	(4630) 
Resolution	(Å) 49.50	–	2.00		
	(2.03	–	2.00) 
47.35	–	2.70		
(2.78	–	2.70) 
73.39	–	1.60		
(1.63	–	1.60) 
CC1/2 0.999	(0.879) 0.992	(0.835) 0.991	(0.343) 
I/σI 21.0	(3.6) 10.5	(2.1) 5.9	(1.7) 
Completeness	(%) 100.0	(99.9) 99.8	(99.7) 90.5	(84.7) 
Redundancy 12.8	(1.4) 3.8	(3.8) 5.1	(5.1) 
    
Anomalous	
completeness	(%) 
99.6	(98.9)   
Anomalous	multiplicity 6.4	(6.1)   
    
Refinement    
Rwork/	Rfree 17.3	/	20.8 21.3	/	28.2	 15.4	/	20.5 
No.	atoms    
				Protein 13898 13926 5630 
				Ligand/Ions 19 36 41 
				Water 686  769 
B-factors    
				Protein 41.8 48.2 20.4 
				Ligand/Ions 32.6 40.8 25.7 
				Water 42.0  34.3 
PDB	Code	 6HZF	 6HZE 6HZG	
 
  
 
 
 
 
 
 
Table 3.  Crystallographic data and refinement statistics. Values in parenthesis are for 
the highest resolution shell. Rfree was calculated using a set (5%) of randomly selected 
reflections that were excluded from refinement. 
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Figure 1. A) Diagrammatic representation of rhamnogalacturnon II (RGII) highlighting the 
cleavage process and linkage cleaved by BT0997; B) The oligosaccharide substrates used in 
this study; C) HPLC chromatograms of 10 µM BT0997, incubated for 16h overnight, against 
the various oligosaccharides, at concentration of >1 mM, demonstrating only substrates with 
double galacturonic acid substitutions on rhamnose are targets for BT0997. All reactions were 
performed in 20 mM sodium phosphate pH 7.0 and 150 mM sodium chloride. 
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Figure 2.  1H-NMR spectra of SN910 treated with BT0997 in D2O. 
A) All reactions were carried out in 20 mM sodium phosphate buffer, pH 7.0, with 150 mM 
NaCl. The concentration of enzyme used was 145 µM against 12.5 mM SN910. Yellow and 
red highlight the signals corresponding to α-GalA and β-GalA, respectively; B and C) Are 
schematic representations of the retaining (double displacement mechanism) and the 
inverting mechanism (single displacement mechanism).  
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Y426
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N520	
E518
H542
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H542
	 	
E294	Y154	Y241	
R332	
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S361	
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W432	
S361	H391	 H391	
H334
	 	
H542
	 	
R521
	 	
-1	
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-1	 -1	 +2NR	
S361	
C-term	loop	
	
C-term	loop	E816	
E816
K357
A	
Figure 3. Structural details of BPA0997. A) Cartoon representation of full length BPA0997, 
left, and C-terminally truncated BPA0997ΔCT, right. The four domains, ND1 (blue), D2 (green), 
D3 (yellow) and CD4 (red) are shown (blue to red from its N to C-terminus). The black arrow 
shows the loop of the CD4 domain locking into the active site of the D2 TIM barrel domain. The 
protein backbone is represented as cartoon. The surface of the protein is shown at 80% 
transparency. B) Active site interactions of BPA0997, left, with GalA shown in yellow, and C-
terminally truncated BPA0997ΔCT, right, with GalA shown in cyan; C) Diagrammatic active site 
interactions of BPA0997, left, and C-terminally truncated BPA0997ΔCT, right.    
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-1 
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+2NR 
Figure 4. Active site of BPA0997ΔCT in complex with two molecules of 
galacturonic acid and a chloride anion. The 2Fobs-Fc electron density map for the 
two bound galacturonic acid residues contoured to 1σ (0.35 e/A3). 
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Figure 5 A and B are both the same analysis of a BLASTP search using BT0997 as 
the subject, in B however, only sequences 415 to 500 are shown for ease of 
visualization. The Black line shows percentage identity of the sequence to BT0997; 
the blue line indicates the percentage of query coverage. 479 out of the 500 
sequences contain both the catalytic residues (E294 and E361) and the critical 
arginine specificity determinants (R332 and R521). The 21 sequences that do not 
contain all four residues are highlighted with red triangles     indicating the absence of 
only R521, upside down magenta triangles      indicate the absence of both 
R332/R521, green diamonds     indicate the absence of R332/R521/E361 and finally 
yellow circles        indicate the absence of R332/R521/E361/E294. 
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